Educell

Educell is a Slovenian biotechnology company based in Ljubljana that specialises in cell- and tissue-based therapies for the regeneration of cartilage, bone and related musculoskeletal tissues. The company is best known for its autologous cell products, in which a patient's own cells are harvested, expanded in the laboratory and re-implanted to repair damaged tissue. Its flagship offering, the Chondro-Gide-style autologous chondrocyte implantation approach marketed under the Cartilage product line, has been used in orthopaedic surgery for knee and joint repair. Educell also develops bone-regeneration products and provides cell-processing services to hospitals and clinics. The company operates from its facility in Ljubljana, Slovenia, and serves the Slovenian market as well as selected international partners. Its work sits at the intersection of regenerative medicine, tissue engineering and orthopaedic surgery, and it has participated in European research projects in the field of cell therapy. Because it is a privately held specialist company, detailed financial and ownership information is not widely published. Educell's positioning is that of a clinical-stage regenerative-medicine provider rather than a mass-market pharmaceutical manufacturer. It supplies surgeons with living-cell implants and related biological materials, and it works closely with academic and clinical institutions in Slovenia and the wider European Union. The company's website, educell.si, presents its product portfolio and its laboratory and clinical services.

Educell is a Slovenian biotechnology company based in Ljubljana. It was established to commercialise cell- and tissue-engineering research carried out in Slovenia, and it has operated as a specialist regenerative-medicine company focused on autologous cell therapies. Its core technology involves taking a small sample of a patient's own tissue, isolating and expanding the relevant cells in a laboratory, and then supplying the resulting living-cell implant to a surgeon for re-implantation into the damaged site. The company's best-known clinical application is autologous chondrocyte implantation for the repair of articular cartilage defects, typically in the knee. Educell has also worked on bone-regeneration products and on cell-based treatments for other musculoskeletal indications. Over time it has built a portfolio that combines laboratory cell-processing services with finished biological implants, and it has collaborated with hospitals, universities and European research consortia in the field of regenerative medicine. Educell operates from a facility in Ljubljana, Slovenia. It serves the domestic Slovenian healthcare market and works with selected international clinical and research partners. As a privately held specialist company, it does not publish detailed financial statements, and its ownership structure is not widely reported. Its public presence is centred on its website, educell.si, which describes its products and services.

Clinical-stage regenerative-medicine and cell-therapy specialist serving orthopaedic surgeons and hospitals.

• Autologous chondrocyte implantation

  A cell therapy in which a patient's own cartilage cells are expanded in the laboratory and re-implanted to repair articular cartilage defects.

• Bone regeneration products

  Cell- and tissue-based products intended to support the repair and regeneration of bone.

• Cell-processing services

  Laboratory services for isolating, expanding and preparing a patient's cells for clinical use.

1. 1Educell — Wikidatawikidata.org
2. 2Educell official websiteeducell.si